The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents
- PMID: 23605059
- DOI: 10.1007/s12149-013-0728-2
The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents
Abstract
Objective: Targeted photodynamic therapy (PDT) is necessary for preventing the side effects associated with PDT, such as photosensitivity caused by the distribution of photosensitizers into normal tissues. In the development of targeted PDT agents, a simple evaluation system of in vivo pharmacokinetics, as well as target cell uptake, is absolutely imperative. We hypothesized that (64)Cu chelation with porphyrin photosensitizer-biomacromolecule conjugates may become a simple and versatile labeling strategy for this purpose.
Methods: Protoporphyrin IX (PPIX) and a bombesin (BBN) analog, that interacts with the gastrin-released peptide (GRP) receptor, were used as a photosensitizer and tumor-targeting peptide, respectively. Then, a conjugate of PPIX and BBN analog linked via short polyethylene glycol (PPIX-PEG6-BBN analog) was synthesized and used as a targeted PDT agent. In addition, a (64)Cu-chelated PPIX-PEG6-BBN analog was synthesized under optimized reaction conditions. Lastly, cell uptake study and PET image-based pharmacokinetic analyses of the PPIX-PEG6-BBN analog were carried out in a human prostate cancer cell line, PC-3, which highly expresses the GRP receptor, and PC-3 tumor-bearing mice.
Results: It was confirmed that degradation (thought to be based on radiolysis) occurs, and large amounts of (64)Cu-labeling compounds are wasted in the reaction mixture. Interestingly, the addition of ethanol into the reaction mixture provides an effective solution for this problem. As for cell uptake study, the [(64)Cu]PPIX-PEG6-BBN analog demonstrated significantly higher uptake for PC-3 cells than [(64)Cu]PPIX and, in addition, the uptake of [(64)Cu]PPIX-PEG6-BBN analog was significantly inhibited by adding excess cold BBN analog peptide. PET image-based pharmacokinetic evaluation revealed that [(64)Cu]PPIX-PEG6-BBN analog and [(64)Cu]PPIX rapidly accumulate into the liver and kidney, circulate in blood for a long time compared with normal peptides, and distribute at a low level in the tumor. This result suggested that in vivo biodistribution of PPIX-PEG6-BBN analog is mainly dependent on the lipophilicity of PPIX. Ex vivo measurements of radioactivity distribution after PET studies showed that although there was no remarkable difference in the tumor/skin ratio of radioactivity between [(64)Cu]PPIX-PEG6-BBN analog and [(64)Cu]PPIX, the pancreas (an organ that also expresses GRP receptors)/skin ratio was significantly higher in the case of [(64)Cu]PPIX-PEG6-BBN analog.
Conclusion: We report on the successful synthesis of (64)Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates under conditions in which radiolysis is suppressed. This labeling strategy with porphyrin photosensitizers may be of value for the rapid development of ideal targeted PDT agents.
Similar articles
-
Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.Nucl Med Biol. 2010 Oct;37(7):751-61. doi: 10.1016/j.nucmedbio.2010.04.016. Nucl Med Biol. 2010. PMID: 20870150
-
Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).Bioconjug Chem. 2012 Aug 15;23(8):1687-93. doi: 10.1021/bc3002437. Epub 2012 Jul 25. Bioconjug Chem. 2012. PMID: 22770480
-
Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.Bioconjug Chem. 2011 Aug 17;22(8):1729-35. doi: 10.1021/bc2002665. Epub 2011 Jul 29. Bioconjug Chem. 2011. PMID: 21761921
-
64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-9-aminonanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2.2011 Jan 2 [updated 2011 Jan 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Jan 2 [updated 2011 Jan 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21290625 Free Books & Documents. Review.
-
64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-6-aminohexanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2.2011 Jan 2 [updated 2011 Jan 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Jan 2 [updated 2011 Jan 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21290624 Free Books & Documents. Review.
Cited by
-
Theranostics with photodynamic therapy for personalized medicine: to see and to treat.Theranostics. 2023 Oct 9;13(15):5501-5544. doi: 10.7150/thno.87363. eCollection 2023. Theranostics. 2023. PMID: 37908729 Free PMC article. Review.
-
Increasing Reaction Rates of Water-Soluble Porphyrins for 64Cu Radiopharmaceutical Labeling.Molecules. 2023 Mar 3;28(5):2350. doi: 10.3390/molecules28052350. Molecules. 2023. PMID: 36903596 Free PMC article.
-
Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine.Molecules. 2022 May 21;27(10):3311. doi: 10.3390/molecules27103311. Molecules. 2022. PMID: 35630788 Free PMC article. Review.
-
Distinctive detection of insulinoma using [18F]FB(ePEG12)12-exendin-4 PET/CT.Sci Rep. 2021 Jul 22;11(1):15014. doi: 10.1038/s41598-021-94595-6. Sci Rep. 2021. PMID: 34294854 Free PMC article.
-
Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor.Nat Chem Biol. 2019 Jun;15(6):598-606. doi: 10.1038/s41589-019-0285-7. Epub 2019 May 17. Nat Chem Biol. 2019. PMID: 31101918
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials